统计学处理数据并进行组间比较。
但大剂量组间比较无显著性差异。
There was no significant difference between HXL and SXJXW at larger dose groups.
组间比较死亡组平均年龄较大。
两组间比较，无显著性差异。
两组间比较差异有显著性。
组间比较采用方差分析。
Differences among groups were compared with analysis of variance.
组间比较采用t检验，采用直线相关分析。
The t test was applied in the intergroup comparison. Linear correlation analysis was used.
血清总蛋白及白蛋白：两组间比较均无显著性差异。
The total protein and albumen in blood serum were similar in two groups.
分别进行治疗前与治疗后的自身前后比较和组间比较。
Comparison group 2: the same as the point injection treatment part in therapy group.
各处理组间比较有17对数据有显著性差异（P<0.05）；
When comparisons were made between each groups, 17 pairs of data exhibited significant difference(P<0.05).
结果术中急性脑膨出及术后脑嵌顿发生率在两组间比较有差异；
Results There was difference in the accurance of intra-operative acute encephalocele and postoperative brain incarceration between two groups.
组间比较分析揭示了进食障碍分量表得分的年龄和区域的显著差异。
Group comparison analyses reveal significant age differences and race differences in several EDI scales.
木通螺内酯组和木通组用药后组间比较免疫组化指标有统计学意义。
As to Mutong spironolactone group and Mutong group, immunohistochemical index has statistical significance compared with each other before and after medicine_taking.
星状神经节阻滞期间两组患者生命体征平稳，组间比较差异无显著性。
The life signs of the two groups were stable during SGB, there was no significant difference.
各疾病严重程度组间比较，IL-2水平无显著性差异（P>0.05）；
There was no statistical difference between levels of IL-2 and severity of illness(P>0.05).
多组间的计量资料比较采用随机分组的方差分析，组间比较采用SNK检验。
The measurement data in multiple groups were compared with randomized analysis of variance and the comparison among groups were performed with SNK test.
从基因型分布频率比较两者间无显著差异；从单倍体分析，两组间比较也无明显差异。
Results There was no difference in the frequencies of allelics, genotypes and haplotypes between the two groups.
二组治疗前后及组间比较肾功能、血糖、血脂、血钾的差异均无显著性（P>0.05）。
No significant difference in biochemistry Parameters could be found between two groups(P>0.05).
红细胞聚集指数两组均见明显降低，但H组比B组降低更明显，两组间比较差异非常显著；
The erythrocyte aggregation index of both groups decreased significantly, but it decreased more significantly in group H and the difference between two groups was significant.
结果：治疗后视力增值、玻璃体混浊、全身症状的组间比较有显著性差异（P＜0．05）；
RESULTS: After treatment the difference of the improvement of visual acuity, vitreous opacities and the systemic symptoms between the two groups was significantive ( P< 0.05);
收集受试者年龄、性别、血压等一般资料以及糖、脂代谢等实验室检查资料，并进行组间比较。
General data such as age, gender and blood pressure and laboratory data such as glucose and lipid metabolism were collected, and comparisons were made between groups.
应用钱氏益黄散加味来治疗小儿慢性腹泻，并与蒙脱石散剂作对照，两组间比较有非常显著性差异。
Apply Qian's revised Yihuang Powder to treat children chronic diarrhea, compared with Mengtuoshi Sanji, there's marked difference between them.
结果PANSS疗前与疗后评分均有显著性差异，疗后2、4、8周各项两组间比较均没显著性差异；
Result There was significant differences on PANSS between pre-and post-treatment, but not on any group of 2, 4, 8 week.
以功效性、安全性和经济学指标作为因变量，以患者其他相关因素作为自变量，进行两组间比较和分析。
Comparison and analysis were conducted in two groups with effect, safety and economic parameters as dependent variables and the other related factors of patients as independent variables.
两组病人的血浆白蛋白水平均下降，但TPN组下降更为明显，组间比较有统计学意义（P<0.05）。
The plasma albumin concentration decreased significantly in two groups and more in TPN group(P<0.05).
结果：治疗组和对照组总有效率分别为72.2%和 67.6%，组间比较无显著差异（P＞0.05）。
Results: The total effective rates were 72.2% and 67.6% in dexzopiclone and control group (P>0.05).
目的探讨医学研究中出现的一类问题，即高危人群检出指标的计算、报告及组间比较的统计学检验的正确性。
Objective To evaluate the calculation and report of detection index and the statistics analysis of group comparison in high risk group, a problem of medical science study.
搏动指数在主动脉、颈动脉、肱动脉、桡动脉、眼动脉及视网膜动脉两组间比较差异均无显著性（P>0.05）。
There were no changes of PI in aortic, carotid, brachial, radial, ophthalmic and central retina arteries (P>0.05).
搏动指数在主动脉、颈动脉、肱动脉、桡动脉、眼动脉及视网膜动脉两组间比较差异均无显著性（P>0.05）。
There were no changes of PI in aortic, carotid, brachial, radial, ophthalmic and central retina arteries (P>0.05).
应用推荐